Recon

Ortho Development Corporation Receives FDA Clearance for Ovation Tribute™ Hip Stem

DRAPER, Utah, April 9, 2014 /PRNewswire-iReach/ — Ortho Development® Corporation has received FDA clearance for its Ovation Tribute™ Hip Stem. The Ovation Tribute is a femoral hip prosthesis that is intended for cementless use in total hip replacement and hemiarthroplasty procedures.

Photo – http://photos.prnewswire.com/prnh/20140409/MN01137

Building off the clinical success of Ortho Development’s Ovation® Hip Stem, the Ovation Tribute incorporates new design features that better accommodate multiple surgical approaches including the direct anterior approach. The Ovation Tribute is a tapered wedge, short stem provided in 12 sizes with standard and extended neck offsets to anatomically accommodate a variety of patients. The proximal region of the stem is coated with titanium plasma spray to provide solid, long-term fixation while the optimized neck geometry of the stem allows for improved range of motion.

The Ovation Tribute is the latest addition to Ortho Development’s hip product line and is designed for use with Ortho Development’s femoral heads and compatible acetabular components. The Ovation Tribute includes a minimal broach-only instrumentation platform.

Ortho Development currently markets its products through a network of independent sales representatives and distributors in the United States and through Japan Medical Dynamic Marketing, Inc. (Japan MDM) in Japan.

About Ortho Development Corporation

Founded in 1994 and headquartered in Draper, Utah, Ortho Development Corporation designs, develops, manufactures, and markets devices for knee and hip joint reconstruction, spine treatment, and trauma fracture repair. Ortho Development is a privately-held company with Japan MDM as the majority owner.  Ortho Development is dedicated to making premium products and delivering superior service and value to its customers.  For more information, visit www.odev.com.

Media Contact: Christopher Little, Ortho Development Corporation, 801-553-9991, clittle@odev.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

 

SOURCE Ortho Development Corporation

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button